Email Newsletters

Life Sciences

Baker signs $623M life sciences bill

Gov. Charlie Baker on Friday signed a $623-million life sciences bond bill to provide funding for education, research and development and workforce training for the industry.

Harvard Bioscience launches inhalation system for researchers

A Harvard Bioscience subsidiary has launched a new inhalation and exposure system for drug research amid rising popularity of drugs taken respiratorily.

Mevion Medical closes $150M investment

Littleton imaging device company Mevion Medical Systems has closed on $150 million in financing primarily from a Chinese pharmaceutical investment firm and private equity investors.

Boston Scientific, Stryker stocks flip flop after takeover talks squashed

The Michigan medical device rival of Marlborough's Boston Scientific said Wednesday it is not in talks to acquire the Massachusetts company despite a report of a potential takeover.
ADVERTISEMENT

Mass. moves ahead of N.J. in life science jobs

Massachusetts is climbing the ladder in the life sciences industry, and has climbed five spots nationwide in terms of jobs since 2003.

Amorsa Therapeutics names biotech law expert to board

Pharmaceutical law expert Jeffrey Wiesen has been appointed to the board of directors for Southborough-based Amorsa Therapeutics, the neuropharmaceutical firm announced Friday.

Biostage appoints former BoA exec new president

A former Bank of America executive who helped the company secure millions in foreign investments has been named the new president of Biostage in Holliston.

RXi leveraging European partnerships to focus on new cancer treatments

Marlborough-based RXi Pharmaceuticals is forging ahead into new territory to create new cancer treatments using its RNAi technology.
ADVERTISEMENT

Milford’s RenalGuard touts success of first in-human study

Milford medical device company RenalGuard Solutions is claiming a recent clinical study has found a new device to help treat heart failure patients.

Biostage names Chinese health care executive to board

Biostage has named another Chinese executive to its board of directors as it seeks to remake itself and explore new markets in different parts of the world.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA